Get the best from your R&D team
December 6, 2006Business Services, Research and Development R&D, recruitment
One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …
New treatment for patients resistant to cancer drug Glivec
December 6, 2006Sales and Marketing
The first effective option for chronic myeloid leukaemia (CML) patients resistant or intolerant to prior treatment with Glivec has been …
Smoking cessation drug launched
December 5, 2006Sales and Marketing
Champix, Pfizer's potential blockbuster smoking cessation drug, has been launched in the UK.This first-in-class treatment is designed to activate the …
PAN Advertising sold to marketing services group Creston
December 5, 2006Medical Communications
One of the UK's last independent healthcare advertising agencies, PAN Advertising, has been sold to marketing services group Creston.Set up …
Cholesterol drug failure hits Pfizer
December 4, 2006Research and Development, Sales and Marketing
Pfizer has suffered a major blow with its decision to cancel late-stage pipeline torcetrapib following safety concerns.Torcetrapib, which raises 'good' …
Galen launches new COPD cough treatment
December 4, 2006Sales and Marketing
Erdotin, a new treatment that reduces the severity of 'productive' or phlegmy coughs in COPD patients, has been launched in …
England set for smoking ban from July
December 1, 2006Sales and Marketing
The United Kingdom will join the ranks of countries to ban smoking in public when, on 1 July 2007, England …
Work to begin on Cancer Reform Strategy for NHS
December 1, 2006Sales and Marketing
The government is to work with doctors, nurses, cancer charities and others to draw up a new Cancer Reform Strategy …
Kindler sets out new vision for Pfizer
December 1, 2006Sales and Marketing Pfizer, lipid
Pfizer's chief executive Jeffrey Kindler has set out plans for the company to renew itself as an R&D, in-licensing and …
Pfizer cuts 2,200 US sales reps
December 1, 2006Sales and Marketing Pfizer, US, job cuts, salesforce
Pfizer has announced a cut of 20% to its US salesforce, a move it says will help it adapt to …
Link Holdings bought by niche pharma company Archimedes
December 1, 2006Sales and Marketing
Archimedes Pharma, a European niche pharma company specialising in nasal drug delivery systems, has bought the UK-based pharma group Link …
AZ sales hit by launch of generic Toprol
November 30, 2006Sales and Marketing AstraZeneca
AstraZeneca's share prices took a dip after news that the company's end-of-year sales figures would be lower than predicted. These …
Merck to diversify its DTC marketing
November 29, 2006Medical Communications
Merck is to spend less money on consumer television advertising in the future and increase its use of targeted media,such …
Takeover will create UK leader in pulmonary products
November 29, 2006Research and Development, Sales and Marketing
Pulmonary product development in the UK has received a boost following the takeover by biotech company Vectura of the drug …
New blindness treatment moves closer to market
November 28, 2006Sales and Marketing AMD, Lucentis, Novartis
Patients suffering from the leading cause of blindness could soon benefit from a new treatment after it gained preliminary approval …
Byetta receives EU approval for Type II diabetes
November 28, 2006Sales and Marketing diabetes
Lilly and Amylin's new diabetes treatment, Byetta, has won EU approval.It is the first in a new class of anti-diabetic …
Bayer beats predictions in third quarter results
November 28, 2006Sales and Marketing
German drug and chemicals company Bayer is forecasting full-year sales of around €30 billion for 2006, following better-than-predicted third quarter …
Can pharma help the NHS to change?
November 27, 2006Sales and Marketing NHS, healthcare, industry relations, strategy
If there has been one constant during the 58 years of the NHS, it has been change - continuous, relentless …
Merck looks to traditional medicine in cancer research
November 20, 2006Research and Development
Merck is to collaborate with traditional medicine company Chi-Med to develop new small molecule anti-cancer drugs from natural products.Chi-Med, based …
A fresh perspective on your business
November 20, 2006Sales and Marketing consultants, marketing
A consultant is someone who borrows your watch to tell you the time- a cynical view of the role of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
